FDA approves groundbreaking new pancreatic cancer drug
The U.S. Food and Drug Administration has approved a new pancreatic cancer drug. Tests showed patients taking it lived longer than before. The articles don't indicate disagreement about this approval.
57 across the spectrum. Choose a side on the bar to jump to it.
National story. 89 articles from 59 sources. 57 are on the bar; 2 are international, entertainment or tech outlets, listed separately. Updated Aug 28, 2026.
Left
15 sourcesGroundbreaking treatments and vaccines offer hope in fight against cancer
Center
32 sourcesNew combination therapy shows promise in metastatic pancreatic cancer
Rep. Sewell praises FDA approval of breakthrough pancreatic cancer drug
Right
10 sourcesFDA Approves ‘Landmark’ Cancer Drug That Extended Patients’ Lives in Trial
FDA approves once-daily pill for deadly cancer after patients' survival rates nearly double
Other outlets
International, entertainment and tech outlets, by their rating. Not counted in the bar above. How we count coverage
Left
2 articlesFDA gives expedited approval to new groundbreaking pancreatic cancer drug
Center
0 articlesNone
Right
0 articlesNone
The story so far
2 developments- Aug 26FDA approves landmark pancreatic cancer drug that’s shown to improve survival
- Aug 27FDA approves pancreatic cancer drug
Who covered each development
No new developments
Quiet for 51 daysLast development · Aug 27 — FDA approves pancreatic cancer drug